Cargando…

Cost-Effectiveness Analysis of Probiotic Use to Prevent Clostridium difficile Infection in Hospitalized Adults Receiving Antibiotics

BACKGROUND: Systematic reviews with meta-analyses and meta-regression suggest that timely probiotic use can prevent Clostridium difficile infection (CDI) in hospitalized adults receiving antibiotics, but the cost effectiveness is unknown. We sought to evaluate the cost effectiveness of probiotic use...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shen, Nicole T, Leff, Jared A, Schneider, Yecheskel, Crawford, Carl V, Maw, Anna, Bosworth, Brian, Simon, Matthew S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2017
Materias:	Major Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5692276/ https://www.ncbi.nlm.nih.gov/pubmed/29230429 http://dx.doi.org/10.1093/ofid/ofx148

Ejemplares similares

Incidence and Costs of Clostridium difficile Infections in Canada
por: Levy, Adrian R., et al.
Publicado: (2015)

Efficacy of Bezlotoxumab in Participants Receiving Metronidazole, Vancomycin, or Fidaxomicin for Treatment of Clostridioides (Clostridium) difficile Infection
por: Dubberke, Erik R, et al.
Publicado: (2020)

Association Between Outpatient Antibiotic Prescribing Practices and Community-Associated Clostridium difficile Infection
por: Dantes, Raymund, et al.
Publicado: (2015)

An Analysis of Clostridium difficile Environmental Contamination During and After Treatment for C difficile Infection
por: Davies, Kerrie, et al.
Publicado: (2020)

Community Environmental Contamination of Toxigenic Clostridium difficile
por: Alam, M Jahangir, et al.
Publicado: (2017)

Learning Data-Driven Patient Risk Stratification Models for Clostridium difficile
por: Wiens, Jenna, et al.
Publicado: (2014)

Changing Results to Change Results: Nudging Antimicrobial Prescribing for Clostridium difficile
por: Herman, Dakoda J, et al.
Publicado: (2020)

Comparison of Control of Clostridium difficile Infection in Six English Hospitals Using Whole-Genome Sequencing
por: Eyre, David W., et al.
Publicado: (2017)

Determinants of Clostridium difficile Infection Incidence Across Diverse United States Geographic Locations
por: Lessa, Fernanda C., et al.
Publicado: (2014)

Increasing Age Has Limited Impact on Risk of Clostridium difficile Infection in an Elderly Population
por: Olsen, Margaret A, et al.
Publicado: (2018)

Using Machine Learning and the Electronic Health Record to Predict Complicated Clostridium difficile Infection
por: Li, Benjamin Y, et al.
Publicado: (2019)

514. The Effect of Probiotics on the Incidence of Clostridium difficile
por: Saltzman, Temima, et al.
Publicado: (2018)

2422. Effectiveness of a Probiotic for Primary Prevention of Clostridium difficile Infection and Antibiotic-Associated Diarrhea among Hospitalized Patients Receiving Broad-Spectrum Antibiotics
por: Le, Khanh-Linh, et al.
Publicado: (2019)

Novel Fidaxomicin Treatment Regimens for Patients With Multiple Clostridium difficile Infection Recurrences That Are Refractory to Standard Therapies
por: Soriano, Melinda M., et al.
Publicado: (2014)

Burden of Nursing Home-Onset Clostridium difficile Infection in the United States: Estimates of Incidence and Patient Outcomes
por: Hunter, Jennifer C., et al.
Publicado: (2016)

Propensity-Matched Cost of Clostridioides difficile Infection Overdiagnosis
por: Madden, Gregory R, et al.
Publicado: (2020)

Impact of an Automatic Hospital Probiotic Protocol on Clostridium difficile Infection Rates and Antibiotic Usage Patterns
por: Slain, Douglas, et al.
Publicado: (2017)

Do Probiotics Prevent Clostridium difficile-Associated Diarrhea?
por: Al Sharaby, Afrah, et al.
Publicado: (2022)

Prevalence and Clinical Outcomes of Clostridium difficile Infection in the Intensive Care Unit: A Systematic Review and Meta-Analysis
por: Karanika, Styliani, et al.
Publicado: (2015)

Clostridium difficile and Antibiotic-associated Diarrhea
por: Bhattacharyya, Mahuya, et al.
Publicado: (2020)

Antibiotics Associated With Clostridium difficile Infection
por: Rafey, Abdur, et al.
Publicado: (2023)

Lactulose may reduce Clostridium difficile‐related diarrhea among patients receiving antibiotics
por: Maltz, Charles, et al.
Publicado: (2020)

The Spore Coat Protein CotE Facilitates Host Colonization by Clostridium difficile
por: Hong, Huynh A, et al.
Publicado: (2017)

A Quaternary Ammonium Disinfectant Containing Germinants Reduces Clostridium difficile Spores on Surfaces by Inducing Susceptibility to Environmental Stressors
por: Nerandzic, Michelle M., et al.
Publicado: (2016)

Clearance of Vancomycin-Resistant Enterococcus Concomitant With Administration of a Microbiota-Based Drug Targeted at Recurrent Clostridium difficile Infection
por: Dubberke, Erik R., et al.
Publicado: (2016)

Effect of a Probiotic on Prevention of Diarrhea and Clostridium difficile and Clostridium perfringens Shedding in Foals
por: Schoster, A., et al.
Publicado: (2015)

Impact of Case-Specific Education and Face-to-Face Feedback to Prescribers and Nurses in the Management of Hospitalized Patients With a Positive Clostridium difficile Test
por: Fabre, Valeria, et al.
Publicado: (2018)

Primary Outcomes From a Phase 3, Randomized, Double-Blind, Active-Controlled Trial of Surotomycin in Subjects With Clostridium difficile Infection
por: Boix, Vicente, et al.
Publicado: (2017)

Oral probiotic combination of Lactobacillus and Bifidobacterium alters the gastrointestinal microbiota during antibiotic treatment for Clostridium difficile infection
por: De Wolfe, T. J., et al.
Publicado: (2018)

In vitro and in vivo antagonistic activity of new probiotic culture against Clostridium difficile and Clostridium perfringens
por: Golić, Nataša, et al.
Publicado: (2017)

Probiotics and Clostridium Difficile: A Review of Dysbiosis and the Rehabilitation of Gut Microbiota
por: Kalakuntla, Ashish S, et al.
Publicado: (2019)

Cost Effectiveness and Cost Containment in the Era of Interferon-Free Therapies to Treat Hepatitis C Virus Genotype 1
por: Linas, Benjamin P., et al.
Publicado: (2016)

Importance of Toxin A, Toxin B, and CDT in Virulence of an Epidemic Clostridium difficile Strain
por: Kuehne, Sarah A., et al.
Publicado: (2014)

Corticosteroids Do Not Increase the Likelihood of Primary Clostridioides difficile Infection in the Setting of Broad-Spectrum Antibiotic Use
por: Carlson, Travis J, et al.
Publicado: (2021)

Comparison of Different Antibiotics and the Risk for Community-Associated Clostridioides difficile Infection: A Case–Control Study
por: Miller, Aaron C, et al.
Publicado: (2023)

Probiotics for the prevention of antibiotic-associated diarrhea and Clostridium difficile infection among hospitalized patients: systematic review and meta-analysis
por: Pattani, Reena, et al.
Publicado: (2013)

A Cumulative Spore Killing Approach: Synergistic Sporicidal Activity of Dilute Peracetic Acid and Ethanol at Low pH Against Clostridium difficile and Bacillus subtilis Spores
por: Nerandzic, Michelle M., et al.
Publicado: (2015)

Changes to the Composition of the Gastrointestinal Microbiome after Probiotics for Clostridium difficile Infection in Adults
por: Eggers, Shoshannah, et al.
Publicado: (2017)

Incidence, Attributable Mortality, and Healthcare and Out-of-Pocket Costs of Clostridioides difficile Infection in US Medicare Advantage Enrollees
por: Yu, Holly, et al.
Publicado: (2022)

Whole-Genome Sequencing Demonstrates That Fidaxomicin Is Superior to Vancomycin for Preventing Reinfection and Relapse of Infection With Clostridium difficile
por: Eyre, David W., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_mv9o1bcbs77sbjnfpvq61ebqis